Opportunity
Federal Register #2026-16732
CDC Awards $30M Sole Source Agreement to Zambia's University Teaching Hospital for HIV and TB Service Improvement
Buyer
Centers for Disease Control and Prevention
Posted
August 17, 2026
Identifier
2026-16732
NAICS
621910
This award announcement details a major funding initiative by the Centers for Disease Control and Prevention (CDC) to improve HIV and tuberculosis (TB) services in Zambia. - Government Buyer: - Department of Health and Human Services (HHS) - Centers for Disease Control and Prevention (CDC) - Award Recipient: - University Teaching Hospital (UTH), Zambia - Scope of Award: - Sole source cooperative agreement for service implementation - Focused on sustainable HIV and TB clinical and laboratory service delivery - Targeted at referral-level hospitals and provincial-level referral facilities - UTH serves as the national reference hospital for these services - Products/Services Requested: - No specific products, part numbers, or purchase quantities listed - Service implementation support for HIV and TB care - Unique Requirements: - UTH is the only entity capable of fulfilling the requirements due to its national referral status - Emphasis on improving advanced HIV disease and TB case management - OEMs and Vendors: - No OEMs or commercial vendors are specified; award is for service delivery, not product procurement - Estimated Contract Value: - Approximately $30,000,000 - Period of Performance: - Five years, with funding for years 2-5 subject to continuation and availability of funds
Description
The Centers for Disease Control and Prevention (CDC), within the Department of Health and Human Services (HHS), announces the award of approximately $30,000,000 for Federal Fiscal Year 2026 funding to Zambia's University Teaching Hospital (UTH), subject to availability of funds. The award aims to improve HIV and TB clinical and laboratory service delivery at referral level hospitals and provincial-level referral facilities through UTH, the national government referral facility. Funding amounts for years 2-5 will be set at continuation. The period of performance is from September 30, 2026, through September 29, 2031.